Bellerophon Therapeutics, Inc. reports

Company location: Warren, NJ
Fiscal year end: 31 December

Bellerophon Therapeutics, Inc. has filed 643 SEC EDGAR filings since 21 Feb 2014

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 276-300 of 643 matching filings.

Per page

25

Current page

12

424B5 File 333-225878

424B5

Filing date: 23 Jan 2019
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36845

8-K

Filing date: 07 Jan 2019
Reporting date: 07 Jan 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36845

8-K

Filing date: 07 Jan 2019
Reporting date: 07 Jan 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 04 Jan 2019
Reporting date: 02 Jan 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 04 Jan 2019
Reporting date: 02 Jan 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 04 Jan 2019
Reporting date: 02 Jan 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 04 Jan 2019
Reporting date: 02 Jan 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 04 Jan 2019
Reporting date: 02 Jan 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 04 Jan 2019
Reporting date: 02 Jan 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 23 Nov 2018
Reporting date: 20 Nov 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 23 Nov 2018
Reporting date: 20 Nov 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 23 Nov 2018
Reporting date: 20 Nov 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 23 Nov 2018
Reporting date: 20 Nov 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 23 Nov 2018
Reporting date: 20 Nov 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 23 Nov 2018
Reporting date: 20 Nov 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36845

8-K

Filing date: 07 Nov 2018
Reporting date: 07 Nov 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-36845

10-Q

Filing date: 07 Nov 2018
Reporting date: 30 Sep 2018
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36845

8-K

Filing date: 24 Oct 2018
Reporting date: 24 Oct 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36845

8-K

Filing date: 16 Oct 2018
Reporting date: 16 Oct 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36845

8-K

Filing date: 09 Oct 2018
Reporting date: 09 Oct 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36845

8-K

Filing date: 27 Sep 2018
Reporting date: 27 Sep 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Sep 2018
Reporting date: 25 Sep 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Sep 2018
Reporting date: 25 Sep 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Sep 2018
Reporting date: 25 Sep 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Sep 2018
Reporting date: 25 Sep 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .